KR101762460B1 - 내산성 캡슐 - Google Patents

내산성 캡슐 Download PDF

Info

Publication number
KR101762460B1
KR101762460B1 KR1020127010224A KR20127010224A KR101762460B1 KR 101762460 B1 KR101762460 B1 KR 101762460B1 KR 1020127010224 A KR1020127010224 A KR 1020127010224A KR 20127010224 A KR20127010224 A KR 20127010224A KR 101762460 B1 KR101762460 B1 KR 101762460B1
Authority
KR
South Korea
Prior art keywords
soluble film
forming polymer
water
gellan gum
film forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127010224A
Other languages
English (en)
Korean (ko)
Other versions
KR20120079836A (ko
Inventor
도미니크 니콜라스 케이드
싱그웨이 데이비드 아슈어
Original Assignee
캡슈겔 벨지엄 엔브이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 캡슈겔 벨지엄 엔브이 filed Critical 캡슈겔 벨지엄 엔브이
Publication of KR20120079836A publication Critical patent/KR20120079836A/ko
Application granted granted Critical
Publication of KR101762460B1 publication Critical patent/KR101762460B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/003—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor characterised by the choice of material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/14—Dipping a core
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D22/00—Producing hollow articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2001/00—Use of cellulose, modified cellulose or cellulose derivatives, e.g. viscose, as moulding material
    • B29K2001/08—Cellulose derivatives
    • B29K2001/12—Cellulose acetate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2003/00—Use of starch or derivatives as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2005/00—Use of polysaccharides or derivatives as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2089/00—Use of proteins, e.g. casein, gelatine or derivatives thereof, as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/712—Containers; Packaging elements or accessories, Packages
    • B29L2031/7174—Capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
KR1020127010224A 2009-09-24 2010-09-14 내산성 캡슐 Active KR101762460B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24539209P 2009-09-24 2009-09-24
US61/245,392 2009-09-24
PCT/IB2010/054131 WO2011036601A1 (en) 2009-09-24 2010-09-14 Acid resistant capsules

Publications (2)

Publication Number Publication Date
KR20120079836A KR20120079836A (ko) 2012-07-13
KR101762460B1 true KR101762460B1 (ko) 2017-07-27

Family

ID=43027570

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127010224A Active KR101762460B1 (ko) 2009-09-24 2010-09-14 내산성 캡슐

Country Status (16)

Country Link
US (4) US8852631B2 (enExample)
EP (1) EP2480218B1 (enExample)
JP (1) JP5777625B2 (enExample)
KR (1) KR101762460B1 (enExample)
CN (1) CN102665697B (enExample)
AU (1) AU2010299527A1 (enExample)
BR (1) BR112012006651B1 (enExample)
CA (1) CA2775227C (enExample)
CO (1) CO6531471A2 (enExample)
DK (1) DK2480218T3 (enExample)
ES (1) ES2804779T3 (enExample)
MX (1) MX2012003540A (enExample)
PL (1) PL2480218T3 (enExample)
RU (1) RU2012116362A (enExample)
TW (1) TW201127370A (enExample)
WO (1) WO2011036601A1 (enExample)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2012116362A (ru) 2009-09-24 2013-10-27 Кэпсьюджел Белджиум Нв Кислотоустойчивые капсулы
WO2013150331A1 (en) 2011-11-09 2013-10-10 Capsugel Belgium Nv Acid resistant banding solution for acid resistant two piece hard capsules
EP2844296B1 (en) 2012-05-02 2019-03-13 Capsugel Belgium NV Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
US12383504B2 (en) 2012-05-21 2025-08-12 Capsugel Belgium Nv Acid resistant banding solution for two piece hard capsules
WO2013174884A1 (en) 2012-05-23 2013-11-28 Capsugel France SAS Capsules having an incorporated taste modifying component
JP2014172850A (ja) * 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
JP6133702B2 (ja) * 2013-06-18 2017-05-24 紀州技研工業株式会社 インクジェットインキ、その製造方法及びその使用方法
EP3065720A1 (en) 2013-11-04 2016-09-14 Capsugel Belgium NV Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
JP6060102B2 (ja) * 2014-03-13 2017-01-11 紀州技研工業株式会社 インクジェットインク及びその作製方法並びにインクジェットインクを用いた印字方法
CN103893772B (zh) 2014-04-21 2015-08-26 湖南尔康制药股份有限公司 一种羟丙基淀粉空心胶囊及其制备工艺
CN103937038B (zh) * 2014-04-28 2016-08-17 中国科学院化学研究所 用于制备空心胶囊的组合物及其淀粉基质空心胶囊
US20170216146A1 (en) * 2014-07-31 2017-08-03 Capsugel Belgium Nv Capsule formulation
JP6297441B2 (ja) * 2014-07-31 2018-03-20 森永乳業株式会社 ビフィドバクテリウム属細菌含有カプセルおよびその製造方法
EP3028694B1 (en) 2014-12-02 2017-07-12 Capsugel Belgium NV Dosage form articles for delayed release
WO2016105498A1 (en) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
EP3244906B1 (en) * 2015-01-13 2020-02-19 New Chapter, Inc. Vegetarian capsules containing supercritical herbal extracts
EP3167880B1 (en) 2015-11-10 2019-06-19 Capsugel Belgium NV Acid resistant banding or sealing solution for acid resistant two piece hard capsules
US20170157058A1 (en) * 2015-12-08 2017-06-08 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process
EP3246000A1 (en) 2016-05-18 2017-11-22 Capsugel Belgium NV Separable capsule for sprinkling applications
EP3272340A1 (en) 2016-07-22 2018-01-24 Capsugel Belgium NV Acid resistant capsules
IL311081A (en) 2016-08-24 2024-04-01 Prilenia Neurotherapeutics Ltd Use of pyridofidine to treat functional decline
JP2018199631A (ja) * 2017-05-26 2018-12-20 株式会社ファンケル ビフィズス菌含有カプセル製剤
US12214084B2 (en) 2017-07-11 2025-02-04 Qualicaps Co., Ltd. Enteric hard capsule
CO2017007322A1 (es) * 2017-07-24 2019-01-31 Novamed S A Cápsulas duras resistentes al ácido con bajo contenido de coadyuvantes de gelificacion
US11865145B2 (en) 2017-08-07 2024-01-09 Finch Therapeutics Holdings Llc Compositions and methods for maintaining and restoring a healthy gut barrier
US11083738B2 (en) 2017-09-28 2021-08-10 Natals, Inc. Dietary nutrient compositions
EP3737750B1 (en) 2018-01-09 2024-06-05 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
US12005086B2 (en) 2018-02-23 2024-06-11 Finch Therapeutics Holdings Llc Microbiome related immunotherapies
US11638699B2 (en) 2018-03-20 2023-05-02 Theriva Biologics, Inc. Intestinal alkaline phosphatase formulations
WO2019183209A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
CN112074567B (zh) * 2018-03-21 2024-04-16 奥驰亚客户服务有限公司 蒸发器胶囊和制造方法
EP3549578A1 (en) * 2018-04-06 2019-10-09 Bio Minerals N.V. Silicic acid formulation and use thereof
US12280153B2 (en) 2018-06-22 2025-04-22 Qualicaps Co., Ltd. Enteric hard capsule
EP3632449A1 (en) 2018-10-05 2020-04-08 Bio Minerals N.V. Silicic acids for use in the treatment of periodontitis
KR102182326B1 (ko) 2019-02-19 2020-11-24 주식회사 서흥 내산성 셀룰로오스 캡슐의 제조방법
US11904056B2 (en) * 2019-03-14 2024-02-20 Evonik Operations Gmbh Capsule shell comprising a core-shell polymer and a cellulose
EP4588511A3 (en) 2019-07-18 2025-07-30 Theriva Biologics, Inc. Intestinal alkaline phosphatase-based treatments of metabolic disorders
PE20221399A1 (es) 2019-07-19 2022-09-15 Finch Therapeutics Holdings Llc Metodos y productos para el tratamiento de trastornos gastrointestinales
US20220331378A1 (en) 2019-09-13 2022-10-20 Finch Therapeutics Holdings Llc Compositions and methods for treating autism spectrum disorder
MX2022004515A (es) * 2019-10-16 2022-07-12 Capsugel Belgium Nv Metodo y composicion para aumentar la sintesis de proteinas musculares.
EP4027990A4 (en) * 2019-10-16 2023-10-18 Capsugel Belgium NV METHOD AND COMPOSITION FOR INCREASE SYNTHESIS OF MUSCLE PROTEIN
CN115279382A (zh) 2019-10-18 2022-11-01 芬奇治疗控股有限责任公司 用于向受试者递送细菌代谢物的组合物和方法
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
WO2021142353A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatitis b (hbv) and hepatitis d (hdv)
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
US20230201265A1 (en) 2020-03-31 2023-06-29 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
IL297885A (en) * 2020-05-31 2023-01-01 Eirgen Pharma Ltd Hard capsule dosage form and its uses
WO2022055993A1 (en) * 2020-09-08 2022-03-17 The Johns Hopkins University Method of treatment of irritable bowel syndrome
CA3199899A1 (en) * 2020-11-25 2022-06-02 Xiongwei He Double layered delayed-release hard capsules
JP7719609B2 (ja) * 2021-02-12 2025-08-06 クオリカプス株式会社 腸溶性硬質カプセル
US20240263251A1 (en) 2021-02-19 2024-08-08 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject
WO2022244713A1 (ja) * 2021-05-18 2022-11-24 ロンザ株式会社 非ゼラチン硬カプセル及びその製造方法
JPWO2023100643A1 (enExample) 2021-11-30 2023-06-08
CN118340904B (zh) * 2024-04-19 2025-04-15 山东赫尔希胶囊有限公司 一种羟丙甲纤维素成膜组合物及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165775A1 (en) * 2002-10-22 2006-07-27 Eastgate Investments Limited Capsule and film-forming composition comprising gum arabic

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144225A (en) 1965-09-07 1969-03-05 Dow Chemical Co Preparation of medicinal capsule shells from hydroxyalkyl-alkyl cellulose ethers
US4756902A (en) 1986-06-02 1988-07-12 Warner-Lambert Company Capsule sealing process and product
US5006346A (en) 1988-04-28 1991-04-09 Alza Corporation Delivery system
US5264223A (en) 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
JP3116602B2 (ja) 1992-10-06 2000-12-11 シオノギクオリカプス株式会社 硬質カプセル
US5431917A (en) 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
JPH07196478A (ja) 1993-12-30 1995-08-01 Hajime Sugii 安全性の高い食品及び医薬品用ソフトカプセル
US5756123A (en) 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
FR2757173A1 (fr) 1996-12-17 1998-06-19 Warner Lambert Co Compositions polymeres d'origine non-animale pour la formation de films
JP4249816B2 (ja) 1997-02-24 2009-04-08 富士カプセル株式会社 ソフトカプセル
US6395298B1 (en) 1997-10-31 2002-05-28 Pharmacia Corporation Gellan gum tablet coating
JP3449253B2 (ja) 1998-10-29 2003-09-22 シオノギクオリカプス株式会社 硬質カプセルの製造方法
DE19926714A1 (de) * 1999-01-25 2000-08-10 Su Heung Capsule Co Pflanzliche Steckkapseln und Verfahren für deren Herstellung
JP3716901B2 (ja) 1999-04-14 2005-11-16 シオノギクオリカプス株式会社 セルロースエーテルフィルム
US6294008B1 (en) 1999-04-21 2001-09-25 The Dow Chemical Company Haze-free cellulose ether capsules and process for making
WO2001007507A1 (en) 1999-07-22 2001-02-01 Warner-Lambert Company Pullulan film compositions
KR100379674B1 (ko) 2000-03-06 2003-04-10 주식회사 서흥캅셀 펙틴과 글리세린의 배합용액을 이용한 셀룰로오스 캅셀 및그의 제조방법
GB2366780A (en) 2000-07-07 2002-03-20 Bioprogress Tech Int Inc Foam capsules
EP1184033A1 (en) 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
JP2002145783A (ja) 2000-11-06 2002-05-22 Kohjin Co Ltd Ｓ−アデノシルメチオニンまたはその塩類を含有するカプセル製剤
US20030072731A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
GB0221986D0 (en) 2002-09-21 2002-10-30 Bioprogress Technology Ltd Films with improved barrier properties
TW200520790A (en) 2003-12-22 2005-07-01 Dah Feng Capsule Industry Co Ltd The compositions of a vegetarian capsule shell
US20070298095A1 (en) 2004-05-24 2007-12-27 Shionogi Qualicaps Co., Ltd. Surface-Modified and Solubility-Improved Hard Capsule
WO2006043284A1 (en) 2004-10-21 2006-04-27 Sunil Mundra A process for manufacturing neutraceutical, pharmaceutical cellulose derivatives capsule
JPWO2006070578A1 (ja) 2004-12-28 2008-06-12 クオリカプス株式会社 硬カプセルのバンドシール
KR100661336B1 (ko) 2005-02-21 2006-12-27 주식회사 서흥캅셀 기계적 피막강도를 향상시킨 셀룰로오스 경질캅셀
WO2006136196A1 (en) * 2005-06-21 2006-12-28 V. Mane Fils Gellan seamless breakable capsule and process for manufacturing thereof
US20070043284A1 (en) 2005-08-16 2007-02-22 Robert Sanfilippo Medical electrode and method of use
EP1762232A1 (en) 2005-09-09 2007-03-14 Warner-Lambert Company LLC Liquid filled delivery system, preferably an HPMC capsule filled with glycerol
US20100233252A1 (en) 2006-01-24 2010-09-16 Qualicaps Co., Ltd. Low-Moisture-Content Hard Capsule and Production Method Therefor
WO2007098612A1 (en) 2006-03-02 2007-09-07 Laboratoires Mauves Inc. Gastric acid resistant gelatin capsule composition and method for producing same
US20080075767A1 (en) * 2006-06-30 2008-03-27 Jin Xiao P Ibuprofen-containing liquid filled hard capsules
ES2744816T3 (es) 2006-10-27 2020-02-26 Capsugel Belgium Nv Cápsulas duras de hidroxipropil metil celulosa y proceso de fabricación
GB0706178D0 (en) 2007-03-29 2007-05-09 Univ Aston Enteric pharmaceutical capsules
WO2009021377A1 (en) * 2007-08-10 2009-02-19 Shanghai Huiyuan Vegetal Capsule Co., Ltd Non-gelatin shell material of hard capsule and process for preparing thereof
EP2223685A4 (en) 2007-11-13 2013-08-21 Shanghai Huiyuan Vegetal Capsule Co Ltd HARD-GEL CELLULAR, GASTRORESISTANT AND GELATIN-FREE ENVELOPE AND PROCESS FOR PREPARING THE SAME
JP5178236B2 (ja) * 2008-02-25 2013-04-10 クオリカプス株式会社 腸溶性カプセル
US8825387B2 (en) 2008-07-25 2014-09-02 Navteq B.V. Positioning open area maps
JP5253235B2 (ja) * 2009-03-02 2013-07-31 クオリカプス株式会社 腸溶性カプセル
CN102470111A (zh) 2009-06-29 2012-05-23 麦克内尔-Ppc股份有限公司 含充液胶囊的药物片剂
US20120164217A1 (en) 2009-09-04 2012-06-28 Dominique Nicolas Cade Scented capsules
RU2012116362A (ru) 2009-09-24 2013-10-27 Кэпсьюджел Белджиум Нв Кислотоустойчивые капсулы
EP2750600B1 (en) 2011-09-14 2017-04-12 Capsugel Belgium NV Fill formulations and capsules and method of use to avoid migration of fill into or through the shell
JP2014172850A (ja) 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
US20170216146A1 (en) 2014-07-31 2017-08-03 Capsugel Belgium Nv Capsule formulation
WO2016099921A1 (en) 2014-12-16 2016-06-23 E. I. Du Pont De Nemours And Company Films, fluoropolymer coated films and highly cleanable articles
TWI587880B (zh) 2015-03-24 2017-06-21 Can be made into the composition of enteric capsule shell, enteric capsule shell and its process
US9452141B1 (en) 2015-05-01 2016-09-27 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process
US20170157058A1 (en) 2015-12-08 2017-06-08 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165775A1 (en) * 2002-10-22 2006-07-27 Eastgate Investments Limited Capsule and film-forming composition comprising gum arabic

Also Published As

Publication number Publication date
TW201127370A (en) 2011-08-16
PL2480218T3 (pl) 2020-11-16
BR112012006651B1 (pt) 2021-11-03
US20120288562A1 (en) 2012-11-15
EP2480218A1 (en) 2012-08-01
AU2010299527A1 (en) 2012-04-19
US20150050334A1 (en) 2015-02-19
CN102665697A (zh) 2012-09-12
DK2480218T3 (da) 2020-08-24
US10231934B2 (en) 2019-03-19
ES2804779T3 (es) 2021-02-09
MX2012003540A (es) 2012-09-07
JP2013505928A (ja) 2013-02-21
WO2011036601A1 (en) 2011-03-31
US9700517B2 (en) 2017-07-11
CA2775227A1 (en) 2011-03-31
EP2480218B1 (en) 2020-05-27
CN102665697B (zh) 2014-07-09
RU2012116362A (ru) 2013-10-27
CO6531471A2 (es) 2012-09-28
US20170231918A1 (en) 2017-08-17
US8852631B2 (en) 2014-10-07
JP5777625B2 (ja) 2015-09-09
US10874619B2 (en) 2020-12-29
CA2775227C (en) 2017-12-19
US20190175514A1 (en) 2019-06-13
KR20120079836A (ko) 2012-07-13
BR112012006651A2 (pt) 2020-08-11

Similar Documents

Publication Publication Date Title
KR101762460B1 (ko) 내산성 캡슐
AU762692C (en) Modified starch film compositions
JP4065691B2 (ja) プルラン膜組成物
JP6626712B2 (ja) 放出制御ポリマーの水性分散液並びにそのシェル及びカプセル
KR101900966B1 (ko) 벌크한 장용성 캡슐 쉘
JP2011500871A (ja) ヒドロキシプロピルメチルセルロース硬カプセルおよび製造方法
JP2004507581A (ja) ペクチンフィルム組成物
EP1593376A1 (en) Improved pullulan capsules
EP1072633A1 (en) Pullulan film compositions
MXPA02000739A (en) Pullulan film compositions

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9